Oruka Therapeutics, Inc.

ORKANASDAQHealthcareBiotechnology

$73.87- (-)1Y +178.13%

As of Oct 15, 2026 close

Market cap: $4.64B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $25.11$115.52
Volume (live): -
Avg. volume (3M): 954.31K

Oruka Therapeutics, Inc. (ORKA) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Oruka Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 12 professional research analysts

Consensus Rating

Buy

Based on 12 unique analysts

(13 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$154.50

+109.15% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest ORKA Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 7, 2026	Yasmeen Rahimi	Piper Sandler	Maintains	Buy	$180.00
Oct 2, 2026	Julian Harrison	BTIG	Reiterates	Buy	$151.00
Sep 24, 2026	Martin Fan	Wedbush	Maintains	Buy	$165.00
Sep 24, 2026	Mitchell Kapoor	HC Wainwright	Reiterates	Buy	$120.00
Sep 24, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Hold	-
Sep 23, 2026	Kaveri Pohlman	Clear Street	Maintains	Buy	$131.00
Sep 23, 2026	Sam Slutsky	LifeSci Capital	Maintains	Buy	$175.00
Sep 21, 2026	Etzer Darout	Barclays	Maintains	Buy	$160.00
Sep 1, 2026	Michael Yee	UBS	Maintains	Buy	$130.00
Aug 26, 2026	Tyler Van Buren	TD Cowen	Maintains	Buy	-
Aug 17, 2026	Yasmeen Rahimi	Piper Sandler	Maintains	Buy	$180.00
Aug 11, 2026	Roger Song	Jefferies	Maintains	Buy	$133.00
Aug 10, 2026	Yatin Suneja	Guggenheim	Reiterates	Buy	$200.00

Yasmeen Rahimi

Piper Sandler

BuyMaintains

$180.00

Oct 7

Julian Harrison

BTIG

BuyReiterates

$151.00

Oct 2

Martin Fan

Wedbush

BuyMaintains

$165.00

Sep 24

Mitchell Kapoor

HC Wainwright

BuyReiterates

$120.00

Sep 24

Zacks Equity Research

HoldInitiates Coverage

Sep 24

Kaveri Pohlman

Clear Street

BuyMaintains

$131.00

Sep 23

Sam Slutsky

LifeSci Capital

BuyMaintains

$175.00

Sep 23

Etzer Darout

Barclays

BuyMaintains

$160.00

Sep 21

Michael Yee

UBS

BuyMaintains

$130.00

Sep 1

Tyler Van Buren

TD Cowen

BuyMaintains

Aug 26

Yasmeen Rahimi

Piper Sandler

BuyMaintains

$180.00

Aug 17

Roger Song

Jefferies

BuyMaintains

$133.00

Aug 11

Yatin Suneja

Guggenheim

BuyReiterates

$200.00

Aug 10

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 7, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for ORKA?

The analyst consensus rating for ORKA is Buy, based on the latest ratings from 12 analysts over the last 90 days.

What is the average price target for ORKA?

The average 12-month price target for ORKA is $154.50, representing an upside of 109.2% from the Oct 15, 2026 close of $73.87.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.